Saturday, June 27, 2026

#oncology biotech

2 articles

Four Oncology Drugs Face FDA PDUFA Decisions in 2026, Stacking Binary Catalyst Risk Into a Narrow Window

Biotech Sector Catalysts

Four Oncology Drugs Face FDA PDUFA Decisions in 2026, Stacking Binary Catalyst Risk Into a Narrow Window

Salvado•Jun 19, 2026

Oncology Biotech Stocks Face Critical Q3-Q4 2026 FDA Decisions Clustering Around Novel Drug Mechanisms

Biotech Equities

Oncology Biotech Stocks Face Critical Q3-Q4 2026 FDA Decisions Clustering Around Novel Drug Mechanisms

Salvado•Apr 18, 2026